Published in Neurosurg Focus on January 01, 2010
Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol (2012) 1.37
MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors. Neuro Oncol (2012) 0.98
Aberrant signaling pathways in glioma. Cancers (Basel) (2011) 0.96
Vascular anomalies: from genetics toward models for therapeutic trials. Cold Spring Harb Perspect Med (2012) 0.91
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. Mol Cancer Ther (2011) 0.90
Diffuse large B cell lymphoma presenting as Horner's syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature. J Med Case Rep (2012) 0.84
Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. Neuro Oncol (2014) 0.84
Plexiform neurofibromatosis involving face and oral cavity. J Oral Maxillofac Pathol (2014) 0.83
Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS One (2013) 0.82
Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing. Int J Mol Med (2014) 0.80
Giant appendiceal neurofibroma in von Recklinghausen's disease: A case report and literature review. Oncol Lett (2014) 0.78
Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages. Oncotarget (2016) 0.77
Spinal neurofibromatosis associated with classical neurofibromatosis type 1: genetic characterisation of an atypical case. BMJ Case Rep (2013) 0.77
Genetic causes of cancer predisposition in children and adolescents. Transl Pediatr (2015) 0.76
Arteriovenous Malformation Underlying a Plexiform Neurofibroma: An Unusual Presentation. Indian Dermatol Online J (2017) 0.75
A reciprocal regulatory loop between TAZ/YAP and G-protein Gαs regulates Schwann cell proliferation and myelination. Nat Commun (2017) 0.75
Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol. Br J Cancer (2015) 0.75
Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric. Mol Syndromol (2012) 0.75
Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient. PLoS One (2015) 0.75
Case Report: A Rosette-forming Glioneuronal Tumor in the Tectal Plate in a Patient with Neurofibromatosis Type I. Cureus (2016) 0.75
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Sci Rep (2016) 0.75
The effect of parental age on the presence of de novo mutations - Lessons from neurofibromatosis type I. Mol Genet Genomic Med (2016) 0.75
[Soft tissue tumors in hereditary tumor syndrome]. Pathologe (2017) 0.75
Impact of fellowship training on research productivity in academic neurological surgery. World Neurosurg (2013) 3.36
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg (2005) 2.19
Molecular characterization of a patient with central nervous system dysmyelination and cryptic unbalanced translocation between chromosomes 4q and 18q. Am J Med Genet A (2003) 2.17
Coincident pituitary adenoma and sellar meningioma. Acta Neurochir (Wien) (2014) 2.01
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature. Spine (Phila Pa 1976) (2003) 1.86
CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders. Am J Hum Genet (2007) 1.82
Pituitary carcinoma: a review of the literature. Neurosurg Focus (2004) 1.77
RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol (2004) 1.76
Ruptured intracranial dermoid cysts: clinical, radiographic, and surgical features. Neurosurgery (2008) 1.69
Primary Intraosseous Skull Base Cavernous Hemangioma: Case Report. Skull Base (2003) 1.63
Metastases to the pituitary gland. Neurosurg Focus (2004) 1.63
Motor proficiency in children with neurofibromatosis type 1. Pediatr Phys Ther (2010) 1.61
Use of the h index in neurosurgery. Clinical article. J Neurosurg (2009) 1.60
Career satisfaction and burnout among U.S. neurosurgeons: a feasibility and pilot study. World Neurosurg (2012) 1.58
Transcortical-transforaminal microscopic approach for purely intraventricular craniopharyngioma. Neurosurg Focus (2013) 1.58
De novo fenestration of the optic nerve. Case illustration. J Neurosurg (2005) 1.58
Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg (2004) 1.55
The combined transmastoid retro- and infralabyrinthine transjugular transcondylar transtubercular high cervical approach for resection of glomus jugulare tumors. Neurosurgery (2006) 1.52
Transnasal excerebration surgery in ancient Egypt. J Neurosurg (2012) 1.48
Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet A (2011) 1.45
Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol (2003) 1.44
The frontotemporal (pterional) approach: an historical perspective. Neurosurgery (2012) 1.41
Tunneled lumbar drain. Technical note. J Neurosurg (2002) 1.39
Patton: death of a soldier. Historical vignette. J Neurosurg (2008) 1.39
Aneurysms of the petrous internal carotid artery: anatomy, origins, and treatment. Neurosurg Focus (2004) 1.36
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A (2010) 1.36
A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am J Hum Genet (2006) 1.31
Brain anomalies in encephalocraniocutaneous lipomatosis. Am J Med Genet A (2007) 1.22
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery (2006) 1.22
Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet (2006) 1.21
Neurosurgical workforce trends in the United States. J Neurosurg (2005) 1.18
Multiple increased osteoclast functions in individuals with neurofibromatosis type 1. Am J Med Genet A (2011) 1.18
Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr (2007) 1.17
Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients. Am J Med Genet A (2007) 1.16
Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus (2004) 1.16
Fenestration of the oculomotor nerve by a duplicated posterior cerebral artery and aneurysm. Case report. J Neurosurg (2009) 1.15
Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies. Am J Med Genet C Semin Med Genet (2011) 1.10
Inflammatory pseudotumor of the cavernous sinus and skull base. Neurosurg Rev (2006) 1.05
Photophobia in a blind patient: An alternate visual pathway. Case report. J Neurosurg (2006) 1.05
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev (2007) 1.04
Hemorrhagic and nonhemorrhagic Rathke cleft cysts mimicking pituitary apoplexy. J Neurosurg (2008) 1.04
SPRED 1 mutations in a neurofibromatosis clinic. J Child Neurol (2010) 1.03
Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg (2003) 1.03
Surgical treatment of craniofacial fibrous dysplasia in adults. Neurosurg Rev (2013) 1.02
Subependymomas: an analysis of clinical and imaging features. Neurosurgery (2006) 1.00
Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet A (2009) 1.00
Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg (2004) 1.00
Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus (2004) 0.98
Porous polyethylene implant for cranioplasty and skull base reconstruction. Neurosurg Focus (2004) 0.98
Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J Neurosurg (2003) 0.97
Surgical approaches for resection of vestibular schwannomas: translabyrinthine, retrosigmoid, and middle fossa approaches. Neurosurg Focus (2012) 0.97
Embolic atrial myxoma causing aortic and carotid occlusion. Surg Neurol (2008) 0.97
Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery. J Neurosurg (2005) 0.97
Familial predisposition to developmental dysplasia of the hip. J Pediatr Orthop (2009) 0.96
Interstitial deletion 8q11.2-q13 with congenital anomalies of CHARGE association. Am J Med Genet A (2005) 0.96
Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg (2007) 0.95
Surgical decision-making strategies in tuberculum sellae meningioma resection. Neurosurg Focus (2011) 0.94
Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care (2005) 0.93
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer (2007) 0.93
Development of contrast enhancement after long-term observation of a dysembryoplastic neuroepithelial tumor. J Neurooncol (2006) 0.93
Incidental meningiomas. Neurosurg Focus (2011) 0.92
Intraventricular tanycytic ependymoma: case report and review of the literature. J Neurooncol (2005) 0.92
Glioblastoma multiforme of the pineal region. J Neurooncol (2006) 0.92
Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. J Neurosurg (2006) 0.92
Rathke cleft cyst intracystic nodule: a characteristic magnetic resonance imaging finding. J Neurosurg (2005) 0.92
Spontaneous hemorrhage associated with a pilomyxoid astrocytoma. Case report. J Neurosurg (2003) 0.92
A comparison of the cell lines used in meningioma research. Surg Neurol (2008) 0.91
Irving S. Cooper and his role in intracranial stimulation for movement disorders and epilepsy. Stereotact Funct Neurosurg (2002) 0.91
Intracranial subarachnoid hemorrhage resulting from cervical spine dural arteriovenous fistulas: literature review and case presentation. Neurosurg Focus (2009) 0.91
Modified infratemporal fossa approach via lateral transantral maxillotomy: a microsurgical model. Surg Neurol (2002) 0.90
Neurofibromatosis type 1 is a genetic skeletal disorder. Am J Med Genet A (2007) 0.90
Ganglion cyst of the temporomandibular joint with intracranial extension in a patient presenting with seventh cranial nerve palsy. J Neurosurg (2011) 0.90
Giant ecchordosis physaliphora in an adolescent girl: case report. J Neurosurg Pediatr (2013) 0.90
Transoral approach and extended modifications for lesions of the ventral foramen magnum and craniovertebral junction. Skull Base (2008) 0.90
A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J Neurosurg (2008) 0.89
Increasing exposure of the petrous internal carotid artery for revascularization using the transzygomatic extended middle fossa approach: a cadaveric morphometric study. Neurosurgery (2006) 0.88
Surgical approaches to pituitary tumors. Neurosurg Clin N Am (2003) 0.88
Neurosurgical implications of allergic fungal sinusitis. J Neurosurg (2004) 0.87
Reconstruction of the skull base after tumor resection: an overview of methods. Neurosurg Focus (2002) 0.87
Myxoid meningioma: a rare metaplastic meningioma variant in a patient presenting with intratumoral hemorrhage. J Neurosurg (2012) 0.87
Rathke cleft cyst presenting with hyponatremia: an unusual presentation. Neurosurg Focus (2011) 0.87
Cystic granular cell tumor mimicking Rathke cleft cyst. J Neurosurg (2010) 0.86
Multimodality treatment for invasive pituitary adenomas. Postgrad Med (2009) 0.86
Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium. J Pediatr Orthop (2013) 0.86
Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurosurg Focus (2006) 0.85
Elevated catecholamine metabolites in patients with Costello syndrome. Am J Med Genet A (2004) 0.85
Total intravenous anesthesia: advantages for intracranial surgery. Neurosurgery (2007) 0.85
Resolution of an anterior-inferior cerebellar artery feeding aneurysm with the treatment of a transverse-sigmoid dural arteriovenous fistula. Skull Base (2007) 0.85
Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A (2010) 0.84
Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg (2002) 0.84
Zones of approach for craniofacial resection: minimizing facial incisions for resection of anterior cranial base and paranasal sinus tumors. Neurosurgery (2003) 0.84
Total hip arthroplasty, hip osteoarthritis, total knee arthroplasty, and knee osteoarthritis in patients with developmental dysplasia of the hip and their family members: a kinship analysis report. J Pediatr Orthop (2012) 0.84
Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Pediatr Res (2008) 0.84
Apoptosis in glioma cells: review and analysis of techniques used for study with focus on the laser scanning cytometer. J Neurooncol (2003) 0.84
Peripheral muscle weakness in RASopathies. Muscle Nerve (2012) 0.83
Giant fusiform aneurysm in an adolescent with PHACES syndrome treated with a high-flow external carotid artery-M3 bypass. Case report and review of the literature. J Neurosurg (2007) 0.83
Contemporary management of prolactinomas. Neurosurg Focus (2004) 0.83
Metastatic melanoma to the pituitary gland. Can J Neurol Sci (2007) 0.83